Politics of the pharmaceutical industry and access to medicines, 

Автор: Brayfield Alison
Название: Martindale
ISBN: 0857111396 ISBN-13(EAN): 9780857111395
Издательство: Pharmaceutical Press
Рейтинг:
Цена: 78408.00 р.
Наличие на складе: Поставка под заказ.

Описание: Martindale: The Complete Drug Reference provides unbiased, evaluated information on drugs and medicines in use around the world. It is updated by an experienced team of pharmacists and life scientists who use their professional expertise to provide an unbiased and evaluated digest of the available literature, selecting the most clinically relevant and appropriate information from reliable published sources. This 38th edition of Martindale has been completely redesigned to ensure ease of use and greatly improved readability.

This latest edition contains over 6000 monographs, including 200 new monographs, on drugs and ancillary substances such as herbals, pharmaceutical excipients, and toxins and poisons. There are over 180,000 preparations giving details of preparation name, manufacturer, ingredients, and uses for proprietary preparations and now covering over 40 countries and regions, including China. The content is evidence-based and extensively referenced with links to the published literature.

Автор: Burdick
Название: Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry
ISBN: 3319501844 ISBN-13(EAN): 9783319501840
Издательство: Springer
Рейтинг:
Цена: 11878.00 р.
Наличие на складе: Есть у поставщика Поставка под заказ.

Описание: This book examines statistical techniques that are critically important to Chemistry, Manufacturing, and Control (CMC) activities.

Автор: Joseph
Название: Pharmaceutical Industry and Public Policy in Post-reform India
ISBN: 1138898422 ISBN-13(EAN): 9781138898424
Издательство: Taylor&Francis
Рейтинг:
Цена: 22968.00 р.
Наличие на складе: Есть у поставщика Поставка под заказ.

Описание:

This book examines the impact of economic reforms in India on the pharmaceutical industry and access to medicines. It traces the changing production and trade pattern of the industry, research and development (R&D) preferences and strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures and their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure -- about 60 per cent -- and characterised by very high share of medicines in total health expenditure.